Andreas Thiel at Berlin Institute of Health Center for Regenerative Therapies - Research Interests, Publications & Academic Profile

Andreas Thiel

Professor

University Name

Germany

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do Nigerian students reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Academic Page

Research Interests

Immunology

60%

Virology

40%

Immune Response

40%

T Cell Biology

30%

Sars-cov-2

30%

Monoclonal Antibodies

20%

Antibody Therapy

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles9

Comparable CD8<sup>+</sup> T‐cell responses to SARS‐CoV‐2 vaccination in single‐cell transcriptomics of recently allogeneic transplanted patients and healthy individuals

Article Link

Year:

2024

Change in body weight of older adults before and during the COVID-19 pandemic: longitudinal results from the Berlin Aging Study II.

Article Link

Year:

2024

Tolerance induction through early feeding to prevent food allergy in infants and children with sensitization against food allergens (TIFFANI): rationale, study design, and methods of a randomized controlled trial.

Article Link

Year:

2024

Primary ChAdOx1 vaccination does not reactivate pre-existing, cross-reactive immunity.

Article Link

Year:

2023

BCL11B depletion induces the development of highly cytotoxic innate T cells out of IL-15 stimulated peripheral blood αβ CD8+ T cells.

Article Link

Year:

2022

Complement activation induces excessive T cell cytotoxicity in severe COVID-19.

Article Link

Year:

2022

Cutting Edge: Serum but Not Mucosal Antibody Responses Are Associated with Pre-Existing SARS-CoV-2 Spike Cross-Reactive CD4+ T Cells following BNT162b2 Vaccination in the Elderly.

Article Link

Year:

2022

SARS-CoV-2 mRNA vaccinations fail to elicit humoral and cellular immune responses in patients with multiple sclerosis receiving fingolimod.

Article Link

Year:

2022

Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination

Article Link

Year:

2021

Collaborators15

Marcel Mueller

Group leader/ Prof. Dr. rer. nat.

Charité - Universitätsmedizin Berlin

GERMANY

Claudia Giesecke-Thiel

Max Planck Institute of Molecular Cell Biology and Genetics

GERMANY

Lucie Loyal

Charité - Universitätsmedizin Berlin

GERMANY

Florian Kurth

Bernhard-Nocht-Institut für Tropenmedizin

GERMANY

Tatjana Tissen-Diabaté

Charité - Universitätsmedizin Berlin

GERMANY

Friederike Kendel

Prof. Dr.

Charité - Universitätsmedizin Berlin

GERMANY

Stephan Michalik

GERMANY

Susanne Lau

Senior Consultant, Professor

Charité - Universitätsmedizin Berlin

GERMANY

Antoine-Emmanuel Saliba

Helmholtz Institute for RNA-based Infection Research

GERMANY

Benedikt Obermayer

Berlin Institute of Health at Charité - Universitätsmedizin Berlin

GERMANY

Eva Tranter

GERMANY

Dieter Beule

Berlin Institute of Health at Charité - Universitätsmedizin Berlin

GERMANY

Chotima Böttcher

Charité - Universitätsmedizin Berlin

GERMANY

Il‐Kang Na

GERMANY

Kathrin de la Rosa

Group Leader/ Professor

Berlin Institute of Health at Charité - Universitätsmedizin Berlin

GERMANY

How do Nigerian students reach out?

Meet Kite AI